NeoGenomics, Inc.
corporate_fare Company Profile
NeoGenomics, Inc. (NASDAQ:NEO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for NEO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for NEO spans 8-K, 10-Q, DEF 14A.
Recent high-impact activity:
- NeoGenomics Q3 Revenue Up 11% to $209M, Raises Full-Year 2026 Guidance
- NeoGenomics Posts 6-Cent Q3 Loss Per Share
- NeoGenomics Plunges 12% as Leadership Shakeup and Q3 Beat Fail to Impress
- NeoGenomics Names Warren Stone CEO, Posts Preliminary Q3 Revenue of $209M
- NeoGenomics Names Warren Stone CEO, Prelim Q3 Revenue Tops $209M
Financial Snapshot
Short Interest & Short Volume
6.67 days to coverFINRA reported short interest of 13,134,507 shares in NEO as of the October 30, 2026 settlement, a 7.6% decrease from the prior period — about 6.7 days to cover at its recent average daily volume. On November 19, 2026, 87.6% of NEO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for NEO, detected from its recent SEC filings · based on capital-structure filings through 2026-06-22.
Finalized Convertible Senior Notes Offering · Premium Conversion Price
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →